simvastatin has been researched along with B16 Melanoma in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (84.62) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Banciu, M; Licarete, E; Luput, L; Mot, AC; Patras, L; Porfire, A; Rakosy-Tican, E; Rauca, VF; Sesarman, A; Toma, VA | 1 |
Banciu, M; Bulzu, P; Licarete, E; Luput, L; Patras, L; Rakosy-Tican, E; Rauca, VF; Sesarman, A | 1 |
Eshita, Y; Hidano, S; Ji, RC; Kamiyama, N; Kobayashi, T; Onishi, Y | 1 |
Imano, M; Kawashima, K; Nishida, S; Obata, N; Satou, T; Tabata, M; Takeda, T; Tsubaki, M | 1 |
Chen, Y; Li, Z; Liu, T; Meng, R; Peng, G; Wu, G; Yu, J; Zhang, S; Zhao, Y | 1 |
Baiano, S; Barra, A; Buommino, E; De Cicco, R; De Filippis, A; Morelli, F; Spampanato, C; Zanfardino, M | 1 |
Alupei, MC; Banciu, M; Cristian, FB; Licarete, E | 1 |
Alupei, MC; Banciu, M; Licarete, E; Patras, L | 1 |
Baba, Y; Kato, Y; Maeda, T; Nishimura, Y; Suzuki, A; Yuzawa, S | 1 |
Contente, TC; Guido, MC; Kretzer, IF; Maranhão, RC; Maria, DA | 1 |
Cha, JS; Kang, K; Kim, JW; Kim, Y; Lee, HG; Lee, MS; Lim, JS; Nam, S; Yang, Y | 1 |
Isozaki, M; Itoh, T; Kaneko, J; Kidera, Y; Nakamura, H; Nishida, S; Ogaki, M; Satou, T; Shoji, K; Tanimori, Y; Tsubaki, M; Yamazoe, Y; Yanae, M | 1 |
Feleszko, W; Jakobisiak, M; Zagozdzon, R | 1 |
13 other study(ies) available for simvastatin and B16 Melanoma
Article | Year |
---|---|
Remodeling tumor microenvironment by liposomal codelivery of DMXAA and simvastatin inhibits malignant melanoma progression.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Disease Progression; Liposomes; Macrophages; Male; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oxidative Stress; Simvastatin; Skin Neoplasms; Tumor Microenvironment; Xanthones | 2021 |
Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells.
Topics: Angiogenesis Inhibitors; Animals; Cell Communication; Cell Movement; Cell Proliferation; Coculture Techniques; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Macrophages; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Simvastatin; Tumor Microenvironment; Xanthones | 2018 |
Role of simvastatin in tumor lymphangiogenesis and lymph node metastasis.
Topics: Animals; Lymphangiogenesis; Lymphatic Metastasis; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Simvastatin; Skin Neoplasms | 2018 |
Combination therapy with dacarbazine and statins improved the survival rate in mice with metastatic melanoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Female; Fluvastatin; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Neoplasms; Melanoma, Experimental; Mice, Inbred C57BL; Signal Transduction; Simvastatin; Skin Neoplasms; Tumor Burden | 2019 |
Endothelial NO synthase and reactive oxygen species mediated effect of simvastatin on vessel structure and function: pleiotropic and dose-dependent effect on tumor vascular stabilization.
Topics: Angiogenesis Modulating Agents; Animals; Antineoplastic Agents; Capillary Permeability; Carcinoma, Lewis Lung; Cell Hypoxia; Cells, Cultured; Cisplatin; Cyclophosphamide; Drug Synergism; Female; Free Radical Scavengers; Human Umbilical Vein Endothelial Cells; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microvessels; Nitric Oxide Synthase Type III; Onium Compounds; Reactive Oxygen Species; Regional Blood Flow; Simvastatin; Tumor Burden; Ultrasonography; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2013 |
Simvastatin reduces melanoma progression in a murine model.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholesterol; Disease Progression; DNA-Binding Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Melanoma, Experimental; Mice; Mice, Inbred C57BL; RNA-Binding Proteins; Simvastatin; Skin Neoplasms; Survival; Survival Rate; Wound Healing | 2013 |
Cytotoxicity of lipophilic statins depends on their combined actions on HIF-1α expression and redox status in B16.F10 melanoma cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma, Experimental; Mice; Necrosis; Oxidation-Reduction; Oxidative Stress; Pravastatin; Simvastatin | 2014 |
Liposomal simvastatin inhibits tumor growth via targeting tumor-associated macrophages-mediated oxidative stress.
Topics: Animals; Blotting, Western; Catalase; Cell Proliferation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit; Liposomes; Macrophages; Male; Malondialdehyde; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Nitric Oxide; Oxidative Stress; Simvastatin; Tumor Cells, Cultured | 2015 |
RhoA mediates the expression of acidic extracellular pH-induced matrix metalloproteinase-9 mRNA through phospholipase D1 in mouse metastatic B16-BL6 melanoma cells.
Topics: Actins; Animals; cdc42 GTP-Binding Protein; Cytochalasin D; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hydrogen-Ion Concentration; Matrix Metalloproteinase 9; Melanoma, Experimental; Mice; Neoplasm Metastasis; Neuropeptides; Phospholipase D; Promoter Regions, Genetic; rac1 GTP-Binding Protein; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; RNA, Small Interfering; Signal Transduction; Simvastatin | 2016 |
Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Proliferation; Cholesterol, LDL; Drug Synergism; Female; Immunoenzyme Techniques; Injections, Intraperitoneal; Lipids; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Paclitaxel; Receptors, LDL; Simvastatin; Tumor Cells, Cultured | 2016 |
Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Topics: Animals; Cell Division; Cell Line, Tumor; Cells, Cultured; Female; Interferon Regulatory Factors; Interleukin-10; Lymphocyte Activation; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myeloid-Derived Suppressor Cells; Myelopoiesis; Nitric Oxide; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Simvastatin; T-Lymphocyte Subsets; Tumor Microenvironment | 2016 |
Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Blotting, Western; Cell Adhesion; Cell Movement; Cell Survival; Extracellular Matrix Proteins; Fatty Acids, Monounsaturated; Female; Fluvastatin; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Integrins; Lim Kinases; Lung Neoplasms; Matrix Metalloproteinases; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myosin Light Chains; Neoplasm Invasiveness; Phosphorylation; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; rho-Associated Kinases; RNA, Messenger; Signal Transduction; Simvastatin; Time Factors | 2010 |
Re: Greying of America will foster new strategies in oncology.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Drug Synergism; Humans; Lovastatin; Melanoma, Experimental; Mice; Simvastatin | 1998 |